Cargando…
Association of the programmed death ligand‐1 combined positive score in tumors and clinicopathological features in esophageal cancer
BACKGROUND: The combined positive score (CPS) of the programmed death ligand‐1 (PD‐L1) 22C3 assay is a predictive marker of pembrolizumab monotherapy for advanced esophageal cancer (EC) patients. However, little is known about the association of the PD‐L1 22C3 CPS with the clinicopathological featur...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841709/ https://www.ncbi.nlm.nih.gov/pubmed/34953041 http://dx.doi.org/10.1111/1759-7714.14285 |